Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

Helicobacter pylori (H. pylori) is the most common chronic bacterial infection, affecting
approximately half of the world's population. H. pylori is a Class I carcinogen according to …

Abstract Background and Aims The optimal management of naïve and not naïve
Helicobacter pylori patients remains unclear. Therefore, it is essential to evaluate whether …

Helicobacter pylori is the most prevalent chronic bacterial infection, with approximately half
of the world's population estimated to be colonized. The World Health Organization (WHO) …

Patients who have failed two or more attempts to eradicate Helicobacter pylori are
commonly referred to as refractory. Although the incidence of refractory Helicobacter pylori …

Background The ideal treatment approach for H. pylori infection has not yet been defined;
therefore, the most effective management strategies for adult patients need to be identified to …

The prevalence of Helicobacter pylori (H. pylori), a pathogen, has decreased globally in the
last decade. To date, the management of H. pylori has focused on a reactive approach …

Helicobacter pylori eradication is characterized by decreasing successful eradication rates.
Although treatment failure is primarily associated with resistance to antibiotics, other …

Abstract Background/Aims In areas with> 15% clarithromycin resistance, bismuth‐based
quadruple therapy is recommended for first‐line Helicobacter pylori eradication. This study …